A Blood Test for Brain Cancer with a Dash of AI Added

Researchers from the University of Strathclyde have developed a blood test that could help to accelerate the diagnosis of brain cancer. The technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer. This research is being commercialized by ClinSpec Diagnostics Ltd, a company spun out from the university in February 2019. The work has now been published in the journal Nature Communications, and also involved clinicians at the Western General Hospital in Edinburgh, the University of Liverpool and the Walton NHS Foundation Trust in Liverpool. Dr. Matthew J. Baker, Reader in Strathclyde's Department of Pure and Applied Chemistry and CSO with ClinSpec Diagnostics, led the study. He said: "This is the first publication of data from our clinical feasibility study and it is the first demonstration that our blood test works in the clinic. Earlier detection of brain tumors in the diagnostic pathway brings the potential to significantly improve patient quality of life and survival, whilst also providing savings to the health services." Patients with brain cancer frequently present with non-specific symptoms and the final cancer diagnosis can be time-consuming. The researchers have analyzed samples from a prospective cohort of 104 patients, they found that the blood test could distinguish patients with brain cancer from healthy individuals correctly 87% of the time. These findings...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Digital Health Source Type: news

Related Links:

How can you have a moonshot trying to cure cancer and not mention people dying of cancer?I believed the narrative that is pushed on women, that if you check your breasts and if you catch it early, you’re fine.ide class="right-rail__container right-rail__container--ad"> Lianne Kraemer had been living with metastatic breast cancer for more than a year when I met her in December 2017 at the Henry B. González Convention Center in San Antonio. Throughout the week, more than 7,000 doctors, scientists and pharmaceutical-company representatives would descend on the city for the country’s most impor...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Breast Cancer health Source Type: news
CANCER symptoms can be difficult to detect because they are similar to those of less serious conditions. Brain tumours can reveal themselves through a range of symptoms, and certain types of headaches may be a warning sign.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conclusions: This study demonstrated a rapid improvement of many symptoms in the subacute post-operative period in pituitary tumor patients. Disturbed sleep was identified as the only symptom to worsen post-operatively, encouraging potential prospective interventions to improve sleep, and subsequently improve the QOL in pituitary tumor patients following surgical intervention. Introduction Pituitary tumors are relatively rare primary central nervous system (CNS) tumors in adults (1) but make up 10% of all neurosurgical interventions in the United States (2). They are often an incidental finding in autopsies and brain...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Conclusion: The efficacy of brainstem gliomas—treated with CyberKnife is efficacious with mild toxicity. Introduction Brainstem gliomas (BSGs) account for 5–15% of brain tumors and more likely happen in children (1). BSGs constitute at least 20% of childhood brain neoplasms (2), and the peak age is 7–9 years. In contrast, BSGs is rare in the adult population and account for only 1.5–2.5% of brain glioma, with a peak age of 40–70 years (1). Diffuse intrinsic pontine glioma(DIPG) was the most common type of BSG is that could invade the whole brainstem including midbrain, pons as well as me...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
ConclusionA solitary cerebellum metastasis from primary gastric adenocarcinoma is a very rare presentation. Early detection of metastatic lesion and successful treatment is challenging.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
ConclusionsDOACs can be safely administered to patients with brain tumors. In patients with primary brain tumors (i.e. glioma), DOACs appear to be safer than LMWH and should be considered for this indication.Figure.DisclosuresZwicker: Incyte: Research Funding; Parexel: Consultancy; Quercegen: Research Funding; Daiichi: Honoraria.
Source: Blood - Category: Hematology Authors: Tags: 332. Antithrombotic Therapy: Poster II Source Type: research
(MediaSource) It wasn't the first wedding anniversary present that Lori Mines was hoping for. After seeking treatment for a debilitating migraine, Lori was diagnosed with advanced stage brain cancer. The prognosis for the disease is usually poor, but researchers are giving some patients with malignant brain tumors new hope for a longer life through research to help predict tumor aggressiveness and survival based on the unique characteristics of their tumors.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
BRAIN cancer symptoms can include weakness, vomiting and drowsiness. But, this is why you should never ignore a headache, as it could be a sign of a brain tumour.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
BRAIN TUMOUR symptoms can include weakness, vomiting and drowsiness. But, this is why you should never ignore a headache, as it could be a sign of brain cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSION Cognitive impairment can affect daily functioning, quality of life, and capacity to work in patients with cancer and those in remission. Consequently, cognitive assessment is now an important and necessary part of a comprehensive oncological care plan. Cancer-related cognitive impairment might be due to the direct effects of the cancer itself, nonspecific factors, or comorbid conditions that are independent of the disease and/or due to the adverse effects of the treatment or combination of treatments given for the disease. The prevalence and extent of cognitive impairment associated with cancer is recognized but...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Cognition Current Issue Neuro oncology Neurology Review cancer chemotherapy cognitive impairment neuropsychological assessment treatment Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Chemistry | Foundation Trusts | Headache | Hospitals | Medical Devices | Migraine | Neurology | Neurosurgery | PET Scan | Study